National Bank of Canada’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-165
Closed -$610 3033
2025
Q4
$610 Buy
+165
New +$533 ﹤0.01% 2680
2025
Q3
Sell
-2,300
Closed -$2.27K 2959
2025
Q2
$2.27K Buy
2,300
+900
+64% +$901 ﹤0.01% 2605
2025
Q1
$2.02K Sell
1,400
-1,050
-43% -$1.94K ﹤0.01% 2506
2024
Q4
$5.39K Sell
2,450
-6,200
-72% -$14.5K ﹤0.01% 2438
2024
Q3
$14.3K Sell
8,650
-10,400
-55% -$21K ﹤0.01% 2005
2024
Q2
$44.2K Buy
19,050
+10,225
+116% +$24.1K ﹤0.01% 1733
2024
Q1
$19.3K Buy
+8,825
New +$21.4K ﹤0.01% 2037
2023
Q2
Sell
-10,446
Closed -$16.6K 2751
2023
Q1
$16.6K Sell
10,446
-96
-0.9% -$496 ﹤0.01% 2019
2022
Q4
$65.7K Sell
10,542
-376
-3% -$2.69K ﹤0.01% 1665
2022
Q3
$73K Sell
10,918
-177
-2% -$1.22K ﹤0.01% 1596
2022
Q2
$70K Sell
11,095
-137
-1% -$777 ﹤0.01% 1663
2022
Q1
$52K Sell
11,232
-1,077
-9% -$4.62K ﹤0.01% 1860
2021
Q4
$61K Buy
+12,309
New +$98.6K ﹤0.01% 1789

Other funds holding ESPR